nexgard spectra chewables for dogs 30.1 - 60 kg
boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 150.0 mg/chew; milbemycin oxime antibiotic active 30.0 mg/chew - parasiticides
nexgard spectra
boehringer ingelheim animal health new zealand limited - milbemycin oxime; afoxolaner - milbemycin oxime 3.75 g/kg; afoxolaner 18.75 g/kg - ectoparasiticide
nexgard spectra 150 mg 30 mg veterinary
beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 150 mg; milbemycin oxime 30 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).
nexgard spectra 19 mg 4 mg veterinary
beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 18.75 mg; milbemycin oxime 3.75 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).
nexgard spectra 38 mg 8 mg veterinary
beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 37.5 mg; milbemycin oxime 7.5 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).
nexgard spectra 75 mg 15 mg veterinary
beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 75 mg; milbemycin oxime 15 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).
nexgard spectra 9 mg 2 mg veterinary
beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 9.375 mg; milbemycin oxime 1.875 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).
dentsply neo spectra st flow flowable composite restorative
dentsply sirona singapore pte ltd - dental - neo spectra st flow composite restorative is indicated for the following procedures: • direct restoration of cavities (except occlusal stress bearing class ii cavities), lesions. • filling of defects and undercuts in crowns, inlays, and onlays. • blockouts. • repair of defects. • pit and fissure sealants. • cementation of light transmissible indirect restorations.
nexgard spectra spot-on solution for cats
boehringer ingelheim animal health new zealand limited - eprinomectin; praziquantel; esafoxolaner - eprinomectin 4 g/litre; praziquantel 83 g/litre; esafoxolaner 12 g/litre - endoparasiticide
terumobct spectra optia apheresis system
terumo bct asia pte ltd - hematology - the spectra optia® apheresis system is a transportable, automatic blood component separator that uses centrifugation and optical detection (automated interface management or aim) to perform therapeutic plasma exchange and mononuclear cell collection procedures.